olfactory receptor family 7 subfamily E member 7 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR7E7P profile across patient tissues and cancer cell-line models. OR7E7P expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, OR7E7P is differentially expressed in 8, with the highest sampling consensus in KIRP. Additionally, OR7E7P RNA expression shows 18,916 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight HNSC, KIRP, and THYM as cancer lineages where OR7E7P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR7E7P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR7E7P survival associations across molecular data types. OR7E7P RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR7E7P RNA expression–survival associations across cancer types. High OR7E7P expression shows unfavorable associations in KIRC, MESO, READ and KICH, but favorable associations in HNSC and THYM. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify HNSC as the clearest survival context for OR7E7P RNA expression.
This table summarizes OR7E7P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for OR7E7P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR7E7P shows lower tumor expression in UCEC and higher tumor expression in KIRP, LUAD, CHOL, LIHC and KIRC. The KIRP box plot shows higher OR7E7P RNA expression in tumor versus normal tissue (log2 FC = +0.479, t-test p < 0.001).
This table shows molecular features associated with OR7E7P in patient tissues and cancer cell lines. In patient samples, OR7E7P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
